7 completed. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
| Phase 2 | 2 | Completed 2 |
Follow tipranavir: new trials by email Literature Review of tipranavir trials Research Report on tipranavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy triple therapy, dual therapy - HIV | Phase 3 | Completed | University Hospital, Tours | 224 | 2014-12-01 | 2025-12-26 |
| Optimizing Treatment for Treatment-Experienced, HIV-Infected People Enfuvirtide, Raltegravir, Darunavir - HIV Infections | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 517 | 2008-01-01 | 2021-11-04 |
| Clinical Trial of CNS-targeted HAART (CIT2) FDA Approved Antiretroviral Therapy (see list below) - HIV Infections | Phase 2 / Phase 3 | Completed | University of California, San Diego | 59 | 2007-03-01 | 2014-04-23 |
| Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options Tipranavir/Ritonavir - HIV Infections | Phase 3 | Completed | Boehringer Ingelheim | 255 | 2004-05-01 | 2013-11-05 |
| Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2) Tipranavir (with low dose ritonavir), Comparator protease inhibitor(CPI)/low dose ritonavir(r) - HIV Infections | Phase 3 | Completed | Boehringer Ingelheim | 882 | 2003-02-01 | 2014-07-02 |
| Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) Tipranavir, Ritonavir(r), Comparator Protease Inhibitor (CPI) - HIV Infections | Phase 3 | Completed | Boehringer Ingelheim | 630 | 2003-01-01 | 2014-07-02 |
| Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects Tipranavir - HIV Infections | Phase 2 / Phase 3 | Completed | Boehringer Ingelheim | 997 | 2001-04-01 | 2014-03-06 |
HIV Infections (6) · AIDS Dementia Complex (1) · Cognitive Dysfunction (1)
Boehringer Ingelheim (4) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Hospital, Tours (1) · University of California, San Diego (1)
United States (4) · France (3) · Germany (3) · Argentina (2) · Australia (2) · Austria (2) · Belgium (2) · Brazil (2) · Canada (2) · Denmark (2) · Greece (2) · Italy (2) · Mexico (2) · Netherlands (2) · Portugal (2)
Karen T. Tashima, MD (1) · Richard H. Haubrich, MD (1)
PMID 16890833, PMID 20003457, PMID 24352352, PMID 26595748, PMID 31135883, PMID 31350995
R01MH058076 (1)